Medtronic Acquires XRT, Gains Brachytherapy Restenosis Technology
This article was originally published in The Gray Sheet
Executive Summary
Medtronic plans to submit an investigational device exemption application in the third quarter for the soft x-ray brachytherapy technology it has obtained as a result of the recent acquisition of privately held XRT Corp.